Related Experiment Video
Updated: Aug 5, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
The Co-Regulation of NLRP3 Inflammasome and Autophagy for Cardiovascular Diseases
Shuxin Zheng1, Huaqian Dou2, Xiao Feng Zhang3,4
1The Affiliated TCM Hospital of Guangzhou Medical University, Guangzhou, China.
Insights
Cardiovascular diseases (CVDs) involve NLRP3 inflammasome activation and autophagy. Targeting these pathways with drugs that promote autophagy can reduce inflammation and improve CVD outcomes.
Area of Science:
- Biomedical Science
- Molecular Biology
- Cardiology
Background:
- Cardiovascular diseases (CVDs) are a major global health concern.
- NLRP3 inflammasome activation is implicated in CVD development.
- Autophagy plays a protective role by clearing cellular debris.
Purpose of the Study:
- To review the roles of NLRP3 inflammasome and autophagy in CVDs.
- To examine how pharmacological agents modulate these pathways.
Main Methods:
- Literature review of studies on NLRP3 inflammasome, autophagy, and CVDs.
- Analysis of drug mechanisms targeting these processes.
Main Results:
- NLRP3 inflammasome and autophagy are key regulators in CVD pathophysiology.
- These pathways interact to influence inflammatory responses.
- Certain drugs inhibit NLRP3 inflammasome by enhancing autophagy.
Conclusions:
- NLRP3 inflammasome and autophagy are critical therapeutic targets for CVDs.
- Pharmacological modulation of autophagy offers a promising strategy for treating CVDs.
Background:
Cardiovascular diseases (CVDs) represent a significant global public health challenge. Activation of the NLRP3 inflammasome contributes to CVD pathogenesis, while autophagy mitigates the condition by eliminating harmful metabolites.
Summary:
Furthermore, NLRP3 inflammasome and autophagy co-regulate CVDs by enhancing autophagic processes, inhibiting inflammasome activity, and reducing inflammatory responses, thus playing a pivotal role in the disease's pathophysiology. Certain pharmacological agents have been shown to inhibit NLRP3 inflammasome activity by promoting autophagy, thereby ameliorating disease pathology.
Key Message:
This review underscores the pivotal roles of NLRP3 inflammasome and autophagy in CVDs and examines the regulatory effects of specific drugs on these processes.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Inflammation
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...